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Summary: We investigated the urinary excretion of ribonucleosides and an unidentified substance in 345
healthy probands from the age of a few weeks to 40 years. The concentration of ribonucleosides, related to
the corresponding concentration of creatinine, decreases until nearly 20 years and remains constant between
20 and 40 years. The polynomial functions describing this dependency are presented. The biological signifi-
cance of our findings is briefly discussed.
Die Altersabhängigkeit der Kreatinin-bezogenen Konzentration von Ribonucleosiden im menschlichen Urin
Zusammenfassung: Die renale Ausscheidung von Ribonucleosiden und einer noch nicht identifizierten Sub-
stanz wurde bei 345 gesunden Probanden unterschiedlichen Alters (wenige Wochen bis 40 Jahre) untersucht.
Die auf den Kreatiningehalt der Urinprobe bezogene Konzentration nimmt etwa bis zum 20. Lebensjahr ab
und bleibt dann bis zum 40. Lebensjahr konstant. Diese Altersabhängigkeit kann mit Hilfe von Polynomial-
funktionen besehrieben werden. Die biologische Bedeutung der Ergebnisse wird diskutiert.
Introduction
 they investigated only small grOups. Schach et al. (l 3)
It has been known for mäny years that degradation found "a narrow correlation between the excretion
products of nucleic acids are excreted in urine. So of nucleobases and growth velocity". In this investi-
far, 50 purine and pyrimidine derivatives have been gation nucleosides were hydrolysed and analysed to-
identified (for general feviews see 1. c. 1-3). gether with the native excreted bases.
The major nucleosides and bases released in the cata- We developed a new procedure which allows the
bolism of nucleic acids are mainly reincorporated determination of ribonucleosides äs well äs nu-
(salvage pathway) or metabolized. On the other hand, cleobases. Thus the aim of our work was to examine
inany of the niodified ones, like pseüdouridine and the age-dependency of excretion of both substances
methylated guaniiie derivatives (which have been äs a basis for diagnosis. In the present paper we
found chiefly in tRNA) seem to be excreted coniple- present the results for the nucleoside analysis.
tely (4, 5). Chaiiges in the normal pattern of excretion
were seen in tumour growth (6 — 8) and disorders of
metäbolism (9 -11). Experimental
Only a little Information is available concerning the Chemicals
äge-dependent excretion of degradation products of The nucleosides, pseüdouridine ( ), cytidine (C), uridine (U),
i · -A D- i + i /A\ **A tr*iAv*m ** *\ / 9 5-aminoimidazole-4-carboxamide riboside, 1-methyladenosine
nucleic acids. Borek et al. (4) and Heldman et al. (12)
 (^^ s-methylcytidine (m'C), inosine (I), guanosine (G), 3-
have observed higher creatinine-related nucleoside methyluridine (m3U), 1-methylinosine (m1!), 1-methylguano-
concentrations in children than in adults. However, sine (mlG), 2-methylguanosine (m2G), adenosine (A), N2,N2-
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dimcthylguanosine (m22G) and tubercidine were purchased
from Sigma, Munich, and used without further purification.
2-pyridone-5-carboxamide-N1-ribofuranoside was a gift from
Prof. Schlimme, Kiel, GFR. Stock Solutions of the nucleosides
were prepared in 0.1 mol/1 forraic acid (conccntration between
3.2 and 5.3 mmol/1). We purchased methanol. ammonium hy-
droxide, formic acid and ammonium dihydrogen phosphate (all
of p. a. grade) from Merck, Darmstadt, GFR, and ammonium
formate (pure) from Riedel de Haen, Hannover. Dowex 1X8
and Affi Gel 601 (Sigma, Munich) were used in the prefrac-
tionation step. Water was double distilled. All buffers were
degassed and filtered through a 0.5 μηι membrane filter (HVLP
04700, Millipore, Bedford).
Samples
Single urines from 345 probands of 0 to 40 years of age (tab.
1) were collected and stored at — 20 °C until analysis. The
urines from adults were mainly supplied by the blood donor
centre of the University hospital Hamburg-Eppendorf (volun-
teer urine given before the first blood donation). Infant urines
were kindly supplied by the Forschungsinstitut f r Kinder-
ern hrung, Dortmund, GFR.
i
H20/CH3OH (80/20; pH 9)
Pump /V0·1 mol/l HCOOH 70.15 mol/l HCOONHA
2 mol/l NaOH
mol/l NH 4 OH/ 0.25 mol/l HCOONHA
Vlmol / l NH4OH/0.'1$ mol/l HCOONH*
0.1 mol/l HCQOH
Nucleo- Nucleo-
bases sides
Fig. 1. Scheme of analysis for the simultaneous extracti n of
ribonucleosides and nucleobases from urine.
Tab. 1. Age and sex distribution of the included healthy pro-
bands.
Sex Age (years)
Female
Male
0-1
0
29
1-5
22
17
5-
10
26
25
10-
15
42
42
15-
20
26
35
20-
40
33
48
0-40
149
196
All probands were clinicaily healthy. The urines were screened
for pH, protein, glucose, ketones, nitrite and erythrocytes (Lab-
stix, Ames, Frankfurt). Samples with abnormal values were
discarded.
To determine the urinary creatinine concentration, we used the
Creatinine Analyser 2 (Beckman, Munich), and each sample
was analysed in duplicate. Fig. 2. Equipment for the HPLC analysis and processing ofdata.
Sample clean-up
The equipment and procedure for the sample clean-up, de-
scribed in detail elsewhere (14, 15), are depicted in figure 1.
Briefly, the deproteinized urine is applied to column l (strong
anion exchanger). UV-absorbing impurities are eliminated
(H2O/MeOH, 80:20; pH 9), then the nucleosides and nu-
cleobases are eluted together (0.1 mol/l HCOOH/0.15 mol/l
HCOONH4) and transferred on line to column 2, wich contains
an affmity gel for cis-diols (Affi Gel 601). Simultaneously the
eluate is mixed with an alkaiine buffer (l mol/l NH4OH/0.15
mol/l HCOONH4). Under these conditions, the nucleosides are
adsorbed on the gel. The bases are not retained and collected
separately. Then the nucleosides are eluted with 0.1 mol/l
HCOOH (fig. 1). *
In contrast to Sander et al. (15), we did not lyoph ize the
nucleoside fraction before the HPLC determination and pseu-
douridine was determined in this fraction (see below).
High performance liquid chromatography
Equipment
The HPLC System consisted of a pump 740 B with pump
control and pressure monitor (Spectra Physics, Darmstadt), an
UV detector model 440 (Waters, K nigsstein), and an Integrator
SP 4100 (Spectra Physics), controlling the autosampler (ASI
120; ABC, Munich). The stainless steel columns (Knauer, Ber-
lin) were heated by an appropriate metal block in combination
with a thermostat (model FK, Haake, Berlin).
Analytical conditions
Pseudouridine: Column 250 χ 4.6 mm, μBondapak C18(Waters), precolumn 50 χ 4.6 mm, Porasil 40 μ (Waters);
mobile phase: 0.01 niol/1 NH4H2PO4 with 1% MeOH; flow
rate l ml/min; temperature 30 °C; detection at 254 nm, 0.05
absorbance units f ll scale; detector attenuation: 1024, sample
volume: 50 μΐ.
Other nucleosides: Column s for Pseudouridine; mobile phase:
0.1 mol/l HCOONH4, adjusted to pH 5 with HCOOH; flow
rate: 1.6 ml/min; temperature: 40 °C; detection at 254 nm, 0.02
absorbance units f ll scale; detector attenuation: 1024; sample
volume: 500 μΐ.
Processing of data
The peak data (height and retention time) were transferred from
the integrator to a PDP 11/34 Computer (Digital Equipment,
Munich) s shown in figure 2. The peaks were identified accor-
ding to their retention time related to the internal Standard
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tubercidine (window ± 3%) and quantified, using the internal
Standard method, with respcct to the dilution factor and crea-
tinine Icvel. In a similar way we calculatcd an s yet unidcntificd
substance "S", assuming an imaginary conccntration in the
calibration Standard. In prcliminary investigations the peaks
were identified by co-chromatography of authcntic nucleosides
in control urines.
The final values werc combincd in a data bank with probands'
personal data to determinc dificrcnt groups for statistical analy-
sis by deliberate selection critcria.
Wc used the method of interpolating cubical splinc function to
caiculatc the curves for the conccntration of ribonuclcosides
and creatinine versus age (17, 18). The fitted curve for each
compound was calculatcd s a polynomial of the 5th degrcc
from l to 40 ycars.
The correlations in pairs. between the conccntration of ribo-
nuclcosides in adults were calculatcd according to M ller et al.(n
The rcquired programs were newly developed or thcy werc
extensions from already existing program listings (SPSS pro-
gram package, SPSS Corp., Chicago).
The systern was automated from the HPLC analysis to the
statistical analysis of the obtaincd data.
Results
The recoveries of the nucleosides depicted in figure
3 a are nearly complete with the exception of m1 A
and m1!, which suffer rather large losses during the
extraction Step (l 5), due to their instability in alkaline
solution (16). Fourteen natural nucleosides and the
internal Standard tubercidine are well separated in
the calibration Standard. However, U, m5C and m2G
coelute with other urinary UV-absorbing com-
pounds.
The following ribonucleosides were included for the
age-dependent urinary excretion analysis: Ψ, C, m1 G,
A, m22G, and an s yct unidentified substance "S".
The Chromatographie behaviour of "S" is identical
with that of authentic 2~pyridone-5-carboxamide-N1-
ribofuranoside using 0.1 mmol/1 HCOONH4, pH 5,
with and without MeOH (volumc fraction 0.05). The
masses however are quitc diffcrent: m/c = 304 for
"S" and m/e * 270 (M+) for 2-pyridonc-5-carboxa-
mide-N'-ribofuranosidc, the latter in accordance with
Schlimme (personal communication).
The creatinine-related conccntrations of ribonucleo-
sides and "S" in urines of adults are summarizcd in
table 2. In no case was the slopc of the regression
lines (concentration versus age, calculated for each
compound separately for females and malcs) different
from zero between l and 40 years, thus indicating
constancy of the urinary conccntrations in adults.
Furthermorc, the values were normally distributcd in
both sexes. The crcatinine-related concentrations of
C, A, m22G, Ψ, and "S" scem higher in women, but
these differenccs were confirmed only for the last
three substances (Sludenfs t-tcst, significance level of
1%). Since the differences are very small, the values
in females and males are considered together in the
following calculations.
The concentrations of some ribonucleosides are cor-
related in pairs in adults. Relatively high correlations
(r > 0.6) were found for the pairs Ψ/πι22Ο and mJG/
m22G (significance level of 0.1%). The corrclation
J
15Λ
0 10 20 30 40 50 60 70Q t tm inJ
Fig. 3. Reversed-phase HPLC Separation of ribonucleosides.
a) Separation of a synthetic mixture (100 μΐ; 0.1 -0.25
nmol of each nucleoside, 0.8 nmol of tubercidine).
b) Separation of the nucleoside fraction of a bealthy
adult (100 μΐ), obtained in the sample clean-up Step.
Chromatographie conditions:
μBondapak C18 (250 χ 4.6 mm),
precolumn Porasil 40 μ, 50 χ 4.6 mm),
eluent: 0.1 mol/1 NH4COOH, pH 5;
flowrate 1.6 ml/min;
detcction at 254 nm, absorbance units f ll scale 0.02;
Integrator attenuation 128.
10 20 30 IQ 50 60 70
t tminJ
Identification:
1: Pscudouridine
3: Uridine
5: 1-Methyladcnosinc
7: Inosihe
9: 3-Methyluridine
11: 1-Methylinosine
13: 2-Mcthylguanosine
15: N2,N2-Dimethylguanosine
2: Cytidine
4: 5-Aminoimidazolc-4-
carboxamidc ri b s i de
6: 5-Mcthylcytidinc
8: Guanosine
10: Tubercidine (IS)
12: 1-Mcthylguanosine
14: Adcnosine
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between the concentration of other nucleoside pairs
(0.3 > r > 0.6) was confirmed at least at the signifi-
cance level of 1%. The concentration of "S" correla-
tes weakly only with that of C and m22G (r = 0.3,
significance level of l %). The corresponding Pearson
coefficients are summarized in table 3.
Up to about 20 years of age, the urinary creatinine-
related concentrations of ribonucleosides and the un-
known substaiice "S" are age-dependent. They are
much higher in infants than in adults (about 3-fold
at one year compared with adults), decreasing rapidly
in the first decade and only slowly thereafter (fig. 4).
Tab. 2. Creatinine-related urinary concentration of ribonucleosides and "S" in adults (20th to 40th year). - r
Substance Concentration (χ ± SD) [mmol/mol creatinine)
Pseudouridine
Cytidine
1 -Methylguanosine
Adenosine
N2,N2-Dimethylguanosine
"S"
females (n = 33)
28.97 H- 4.05
0.97 + 0.18
0.99 ± 0.15
0.44 ± 0.12
1.28 + 0.22
89.94 + 17.2
males (n = 48)
26.24+ 4.54
0.88 ± 0.12
1.01 ± 0.14
0.41 -h 0.13
1.15 + 0.15
73.16 ± 13.10
females + males (n = 81)
27.35 ± 4.53
0.92 + 0.15
1.00 ± 0.14
0.42 + 0.12
1.20 ± 0.19
80.00 + 17.18
Tab. 3. Pearson correlation coefficients (healthy adults).
Cytidine
1 -Methylguanosine\
Adenosine
N2,N2-Dimethylguanosine
"S"
Pseudouridine
0.5383**)
0.4294**)
0.3951**)
0.6312**)
0.2586
Cytidine
0.4773**)
0.4183**)
0.5695**)
0.3017*)
1 -Methyl-
guanosine
0.3098*)
0.6775**)
0.0247
Adenosine
0.2707*)
0.0298
N2,N2-Dimethyl-
guanosine
0.3175*)
Significance level: *) 1% **) 0.1%
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Tab. 4. Coeflficients (ao to as) for the calculated polynomials of the 5th degree (y
= age (years), y = nucleoside concentration (mmol/mol creatinine).
a0 + atx 4· a5x5).
Substance ai a2 · E-2 a3 - E-3 a4 · E-5 a5 · E-7
Pseudouridine
Cytidine
1 -Methylguanosine
Adenosine
N2,N2-Dimethylguanosine
"S"
90.7965
3.2179
3.7391
1.7257
4.9962
267.6770
-11.3582
- 0.3775
- 0.4364
- 0.1868
- 0.6625
-20.3109
89.4017
2.6121
2.8225
0.8996
4.9201
68.9660
-35.7579
- 0.9022
- 0.9134
- 0.1313
- 1.8660
- 3.8660
68.6442
1.5017
1.4699
- 0.1186
3.4997
-20.3940
-49.5299
- 0.9466
- 0.9350
0.3085
- 2.5459
29.2180
Since the Variation of the creatinine-related nucleo-
side concentration is relatively high during the first
year of life, these values have been excluded from the
curve fitting. The rounded arguments a0 to as of
the polynomial of the 5th degree are summarized in
table 4.
Figure 5 shows the fitted curves, expressed as the
fraction of the function value of infants. The curves
of the ribonucleosides as well of the unidentified
substance "S" are nearly coincident, thus indicating
an unchanged excretion pattern throughout develop-
ment.
1.00
-S 0.50
o
UL 20
Age CyearsJ
30
Fig. 5. Bündle of fitted curves (creatinine-related nucleoside
concentration versus age) as the fraction of respective
value at one year of age.
6.00
S 4.oo
o
*o
J
| 2.00
1.00
Creatinine
10 15
Age LyearsJ
20
Fig. 6. Mediän pseudouridine arid creatinine concentration of
the analysed urines. Curves as the fraction of respective
function value at one year of age.
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The fitted curves of the concentration of creatinine
and pseudouridine (as example for the remaining
nucleosides) in the analysed urines, expressed as the
fraction of function value at one year of life, are
depicted in figure 6. The creatinine level in adults is
about six times higher than in one year old toddlers
and it increases especially during the first decade. The
pseudouridine concentration increases only twice as
much and reaches a plateau between 10 and 15 years
oflife.
Discussion
We examined the urinary excretion of major and
modified ribonucleosides and an as yet unidentified
substance "S" from 345 healthy probands of different
ages. The data should supply basic Information for
investigations on the excretion of RNA degradation
products for diagnostic purposes.
Earlier investigations have shown that creatinine, a
measure of muscular mass (19), is a reliable baseline
for the quantitative determination of RNA break-
down products in urine, as the relation between RNA
catabolite and creatinine concentration in spot sam-
ples is very similar to that in 24-h urines (6, 20).
One has to consider, however, that certain dietary
regimens and pharmaceuticals influence the excretion
of creatinine (19, 21), and that some pharmaceuticals
can interfere with the determination of this com-
pound (22).
The creatinine-related urinary concentration of nu-
cleosides and the unidentified substance were found
to be constant in adults (aged 20 to 40 years). Our
data correlate quite well with data of other groups
(20, 23, 24). We cannot exclude the possibility that
the nucleoside-creatinine ratio is influenced by the
lower creatinine excretion in older people (25, 26).
Results of Rasmuson et al. (27) seem to disprove
this supposition, whereas Tritsch et al. found higher
(about 3-fold) pseudouridine/creatinine values in
older adults than in younger ones (28).
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Like Speer et al. (23) we found slightly higher values
for some nucleosides in women, which contradicts
the fmdings of other groups (27, 29). So it is not clear
whether sex-dependent differences indeed exist.
In children and adolescents the creatinine-related
concentration of nucleosides is obviously age-depen-
dent. Hovvever the decrease of concentration is not
linear äs Heldman et al. (12) suspected, but can be
described for each compound to a good approxima-
tion by a polynomial of 5th degree. The curves were
calculated using the cubical spline function to get
straight fitted curves without a fixed mathematical
model, and to assure a sensible adjustment procedure
for course deviations. In contrast to earlier investiga-
tions on the excretion of nucleobases, and despite
higher case numbers, we observed no increase of the
creatinine-related nucleoside concentration in pu-
berty (fig. 4). The dynamics observed by Schach et
al. (13) may be caused by the native excreted nu-
cleobases, which were determined together with the
hydrolysed nucleosides. However this seems less pro-
bable, since the course of N2,N2-dimethylguanosine
equals that of the other nucleosides (fig. 5). So far,
we have been unable to detect the corresponding base
in any urine (unpublished results).
The courses of the creatinine-related concentration
of the investigated nucleosides during development
are nearly coincident (fig. 5). This suggests an un-
changed excretion pattern throughout childhood and
adulthood. According to observations of Sander et
al. (30), this is also true of preterm infants, which
contradicts earlier fmdings of a deviant nucleobase
pattern during the first months of life (6).
As shown above, the concentrations of some ribo-
nucleosides are relatively highly correlated in pairs.
Consecutively we can describe not only an univariate
but also a multivariate normal ränge. The usefulness
of such a procedure for diagnostic purposes has been
demonstrated by Müller et al. (7). Based on the calcu-
lated polynomials we are able now to ascertain any
shift between nucleoside and creatinine excretion and
also pathological changes in nucleoside excretion pat-
tern caused by tumour growth or other diseases in
infants äs well in adults (Müller-Wickop et al., in
preparation). Only two milliliters of urinary spot sam-
ples are needed for this purpose.
To Interpret the age-dependent dynamic of the crea-
tinine-related urinary ribonucleoside concentration
we have calculated the curves of the underlying crea-
tinine and pseudouridine concentratjon (representa-
tive for the remaining ribonucleosides) in the analysed
urines. As shown in figure 6, the course of the concen-
tration of both substances versus age is quite dif-
ferent. Whereas the creatinine concentration in-
creases about 6-fold, the nucleoside concentration
increases only two-fold from the first year to adult-
hood. This suggests a higher metabolism of ribo-
nucleic acids in infants related to the muscular mass.
Based on literature data concerning the creatinine
output per body mass, Sander et al. (31) calculatecl
that metabolism in preterm infants is about 2—4
times higher than in adults.
The overall RNA metabolism, however, can be deter^
mined correctly only by measurement of the RNA
catabolites in 24 h urines. It seems to be remarkable
that the daily creatinine Output appears about 3—4
fold higher in adults than in infants (32, 33). On the
other hand, the creatinine-related. nucleoside concen-
tration is about 3-fold higher in infants than in adults,
äs shown above. So we can assume that the daily
excretion of RNA catabolites is not very different in
both groups. This supposition however remains to be
proved.
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